Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Can NervGen keep a lid on explosive news?

Speculation of early “evidence” of successful proof-of-concept human trials sparks stock rallies Trial volunteers taking a placebo are offered the real deal in a follow-up trial as a “reward” The company&Clo...
Knox Henderson | March 20, 2024 |

Is this stunning 'evidence' that NervGen has the goods?

This could be the signal that tiny NervGen Pharma Corp. (TSX-V:NGEN; OTCQX:NGENF) is destined to be one of the top performing biotech startup stocks this year. It came in a seemingly innocuous podcast interview about the company’s ongoing Phase 1b/2...
Knox Henderson | February 1, 2024 |

Buzz on the Bullboards: Who’s filling the void in the tech selloff?

Last week was full of tough questions for investors navigating the waters of a sea of global economic uncertainty and confusion. Investors remain in a holding pattern as we witnessed some of the most popular companies among our communities (many in the tech sector) st...
Jonathon Brown | February 1, 2024 |

ExoTherapy offers hope for treating acute spinal cord injuries

Suffering from traumatic injuries can leave a person with long-term damages and/or side effects that are hard to navigate long after the initial incident has passed. Our next company is a publicly traded bio-pharmaceutical company, working on the development of its ...
Brieanna McCutcheon | September 19, 2023 |

Western Exploration's Aura project is well positioned in Nevada

Western Exploration (TSXV:WEX) is a Nevada-based gold and silver exploration company. CEO Darcy Marud has more than 30 years of precious metals experience in the Americas and is an active member of the Association of Professional Geoscientists of Ontario. He provides up...
Coreena Robertson | August 31, 2023 |

A Petroleum Co. That’s Poised & Positioned to Help Fill the Global Energy Void

The Russian invasion of Ukraine has shone a bright light on the need for the west – particularly Europe – to find alternative sources of energy and to break its dependence on Russian oil and natural gas. That’s where companies like ShaMaran Petroleum C...
Dave Jackson | May 13, 2022 |

Siyata Mobile Accelerating Growth on Multiple Fronts

Expands its Global Footprint with Multiple New Contracts and a Key E-Commerce Distribution Agreement and Launches Innovative New Product Focusing on one specific niche market has long been a proven path to success. It’s also a potential road to failure if y...
Featured Submission | September 29, 2021 |

Best-in-class Cannabis = Best-in-class Investment Opportunity

(CLICK IMAGE TO PLAY VIDEO) Today, in the publicly-traded retail cannabis sector, you need to deliver not only a quality, brand-name product but consistent shareholder value. Enter the new name in the game – Chalice Brands Ltd. ( CSE.CHAL , OTCMKTS: CHALF...
Dave Jackson | July 8, 2021 |

NervGen Pharma: A “Blockbuster Drug” in the Making?

It has the potential to be one of the most disruptive pharmaceutical drug therapies of the modern era, especially for treating Alzheimer’s disease. And that gives it considerable “blockbuster drug” potential – a tantalising opportunity tha...
Marc Davis | June 25, 2021 |

A Unique Petro Play Offering Quality, Growth, and Cash Flow

(Click image to play video) With energy stocks gaining as oil climbs as the result of supply concerns, the oil and gas sector is seeing a significant resurgence in investment and investor confidence. What many people don’t know is that sector spe...
Dave Jackson | April 7, 2021 |
1 2 3 4 5 6